Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 1041 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Allozymes Expands Global Footprint, Establishes European Subsidiary to Fuel Bioeconomy Advancement

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024
Related companies:  Allozymes, Pte. Ltd.

Spravato® Therapy at Hudson Mind Ushers in New Era of Accessible Care for Treatment-Resistant Depression

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024

Avirmax Inc. to Make Scientific Presentations at ASGCT in Baltimore

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024
Related companies:  Avirmax, Inc.

Nebulizer Market Projected to Reach $3.97 billion by 2030 - Exclusive Report by 360iResearch

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024

Multicancer Screening Market Projected to Reach $2.72 billion by 2030 - Exclusive Report by 360iResearch

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024

Active Nutraceuticals Ingredients Market Projected to Reach $392.58 billion by 2030 - Exclusive Report by 360iResearch

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024

StateHouse Appoints Felicia Snyder as Independent Chair of the Board

Read more ››
By: GlobeNewswire - 16 Apr 2024

TLX101-CDx (Pixclara™) Granted FDA Fast Track Designation

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024
Related companies:  Telix Pharmaceuticals Limited

International Fellowship of Christians and Jews Mobilizes to Provide Emergency Aid in Response to Iranian Attacks

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024

INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024
Related companies:  Inovio Pharmaceuticals, Inc.

Innovent Announces the Appointment of Dr. Nageatte Ibrahim as the Oncology Chief Medical Officer (CMO)

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024
Related companies:  Innovent Biologics (USA), Inc.

Teladoc Health Provides Updated Start Time for First Quarter 2024 Earnings Call on April 25

Read more ››
By: GlobeNewswire - 15 Apr 2024
Related companies:  Teladoc, Inc.

SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024

Read more ››
By: GlobeNewswire - 15 Apr 2024

Bile Tract Cancer expansion study opens following clearance of Imugene’s MAST trial high dose cohort

Read more ››
By: GlobeNewswire - 15 Apr 2024
Related companies:  Imugene Limited

GENFIT Annual Combined General Meeting of May 22, 2024 — Availability of Preparatory Documents

Read more ››
By: GlobeNewswire - 15 Apr 2024
Related companies:  GENFIT

Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders

Read more ››
By: GlobeNewswire - 15 Apr 2024
Related companies:  Theratechnologies Inc.

ORIC Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1b Trial of ORIC-114 in Patients with Mutated NSCLC

Read more ››
By: GlobeNewswire - 15 Apr 2024
Related companies:  Oric Pharmaceuticals Inc.

Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million

Read more ››
By: GlobeNewswire - 15 Apr 2024
Related companies:  Outlook Therapeutics, Inc.

BioSyent Announces Extension of RepaGyn® and Proktis-M® Agreement

Read more ››
By: GlobeNewswire - 15 Apr 2024
Related companies:  BioSyent Inc.

Zevra Therapeutics Presents New Data on the Long-Term Safety and Efficacy of Arimoclomol as a Treatment for Niemann-Pick Disease Type C at the SIMD 45th Annual Meeting

Read more ››
By: GlobeNewswire - 15 Apr 2024
Related companies:  Zevra Therapeutics, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑